Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 8, 2008

Thermo Fisher Scientific Opens Clinical Services Facility in India

  • Thermo Fisher Scientific opened its new $17 million clinical services facility in Ahmedabad, India. The 150,000-square-foot facility will provide biopharma services in the region, serving as a hub for packaging, global distribution, and logistics management of pharmaceutical samples to patients participating in clinical trials. It complements the company’s existing clinical services operations in the U.S., Europe, and Asia.

    “We continue to make the investments required to grow our business—in this case expanding our capabilities to support growing clinical research and development markets in India,” said Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. “With the added capacity now available to us with this new facility, we can offer our customers a higher level of technology, quality, and expertise to facilitate clinical trials that serve the needs of both local and multinational pharmaceutical companies.”

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »